ClinConnect ClinConnect Logo
Search / Trial NCT06770101

Suicide Assessment and Feasible Evidence-based Treatments for Youth Living with HIV in Lilongwe

Launched by UNIVERSITY OF PENNSYLVANIA · Jan 9, 2025

Trial Information

Current as of November 14, 2025

Not yet recruiting

Keywords

Hiv Suicide Suicidal Ideation

ClinConnect Summary

This clinical trial is looking at a new way to help young people living with HIV who might be struggling with thoughts of suicide or self-harm. The study will compare a special program called the Friendship Bench + Safety Planning with regular care to see if it can effectively reduce these feelings and encourage better engagement with HIV treatment. The goal is to find out how well this program works and how acceptable it is for teenagers.

To be part of the study, participants need to be between 13 and 19 years old, diagnosed with HIV, and have experienced thoughts or behaviors related to suicide. They also need to live in the area where the clinic is located and plan to stay there for at least a year. Participants will be asked to share their experiences during interviews, and those who are 16 or older may need to get permission from a parent to take part. This trial is important because it aims to provide better support for vulnerable youth, helping them live healthier and more fulfilling lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age 13-19
  • Diagnosed with HIV
  • Report current or historical suicidal ideation and behaviors (SIBs) on question 9 of the Patient Health Questionnaire modified for adolescents (PHQ-9-A) and the Ask Suicide-Screening questionnaire (ASQ)
  • Living in the clinic's catchment area with intention to remain for more than 1 year
  • Willing to provide consent (age 18+ or 16-17 years old and married and thereby considered emancipated minors per Malawi law) or assent with parental consent (age 13-17).
  • Exclusion Criteria:
  • Refuse to participate
  • Refuse to be audio-taped for in-depth interviews

About University Of Pennsylvania

The University of Pennsylvania, a prestigious Ivy League institution located in Philadelphia, is renowned for its commitment to advancing medical research and improving healthcare outcomes. As a clinical trial sponsor, the university leverages its extensive resources, interdisciplinary expertise, and cutting-edge facilities to conduct innovative studies across various therapeutic areas. With a focus on translating scientific discoveries into clinical applications, the University of Pennsylvania fosters collaborations among leading researchers, clinicians, and industry partners, ensuring rigorous trial design and adherence to ethical standards. Through its dedication to excellence in research and education, the university plays a pivotal role in shaping the future of medicine.

Locations

Lilongwe, Malawi

Lilongwe, Malawi

Lilongwe, Malawi

Lilongwe, Malawi

Patients applied

0 patients applied

Trial Officials

Melissa Stockton, PhD

Principal Investigator

University of Pennsylvania

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported